Heparin‐Induced Thrombocytopenia and Thrombosis in Patients With or Without a Thrombophilia Background: A Systematic Review Involved 602 Cases
International Journal of Vascular Medicine · 2025-01 · 2025 (1)
DOI: 10.1155/ijvm/9338124 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Vascular Medicine, online erschienen am 29.12.2025. Verfasst von Guangyu Han und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China, ccmu.edu.cn. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Heparin‐induced thrombocytopenia (HIT), often accompanied by thrombotic events and collectively referred to as heparin‐induced thrombocytopenia and thrombosis (HITT), is worthy of attention. Herein, we analyzed the features of HITT in patients with or without a thrombophilia background present prior to heparin exposure, aiming to identify and customize treatment.
Methods
We searched PubMed and EMBASE to identify studies published up to November 2024, via the keywords “heparin,” “thrombocytopenia,” “thrombosis,” and “thrombophilia.” Case series and reports with confirmed HITT were included.
Results
A total of 602 patients (277 males and 325 females with a mean age of 57.00 ± 17.20 years), reported in 481 papers, were carefully analyzed. The median time of thrombocytopenia and thrombosis onset postheparin exposure was Day 9 (5–12) and Day 9 (6–12), respectively. The abnormal platelet counts recovered by Day 5 (3–7) after the cessation of heparin. A more pronounced platelet count reduction was shown in patients with a thrombophilia background than those without this entity ( p = 0.004). In this HITT cohort, patients with a thrombophilia background were more likely to develop newly formed venous thrombosis, whereas those without thrombophilia were more prone to arterial thrombosis after heparin use. Anti‐platelet factor 4 (PF4)/heparin antibody assay was the mainstream diagnostic method for HITT.
Conclusions
HITT typically presents as newly formed venous thrombosis in patients with a thrombophilia background and as arterial thrombosis in those without thrombophilia. Whereby, screening for thrombophilia in patients with HITT is suggested, as well as considering prolonged alternative anticoagulation therapy in patients with a thrombophilia background.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China, ccmu.edu.cn.
- Division of Neurocritical Care and Emergency Neurology, Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA, harvard.edu.
- Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China, bibd.ac.cn.
- National Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, Beijing, China, ccmu.edu.cn.
ORCID-Profile: Guangyu Han, Da Zhou, Ran Meng
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Han, G., Song, S., Wan, S., Wang, M., Zhou, D., Ji, X., & Meng, R. (2025). Heparin‐Induced Thrombocytopenia and Thrombosis in Patients With or Without a Thrombophilia Background: A Systematic Review Involved 602 Cases. International Journal of Vascular Medicine, 2025(1). https://doi.org/10.1155/ijvm/9338124
Vancouver
Han G, Song S, Wan S, Wang M, Zhou D, Ji X, et al. Heparin‐Induced Thrombocytopenia and Thrombosis in Patients With or Without a Thrombophilia Background: A Systematic Review Involved 602 Cases. International Journal of Vascular Medicine. 2025;2025(1). doi:10.1155/ijvm/9338124
BibTeX
@article{Han2025,
author = {Han, Guangyu and Song, Siying and Wan, Shuling and Wang, Mengqi and Zhou, Da and Ji, Xunming and Meng, Ran},
title = {Heparin‐Induced Thrombocytopenia and Thrombosis in Patients With or Without a Thrombophilia Background: A Systematic Review Involved 602 Cases},
journal = {International Journal of Vascular Medicine},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/ijvm/9338124}
}
EUVIMED